Sign in or Register   Sign in or Register
  |  

Mouse Anti-Tsc2 Recombinant Antibody (249CT19.1.3) (CBMAB-T4518-YJ)

Provided herein is a Mouse monoclonal antibody, which binds to Tsc2 (Tuberous Sclerosis 2). The antibody can be used for immunoassay techniques, such as IF, IHC-P, WB.
See all Tsc2 antibodies

Summary

Host Animal
Mouse
Specificity
Mouse
Clone
249CT19.1.3
Antibody Isotype
IgG1, κ
Application
IF, IHC-P, WB

Basic Information

Specificity
Mouse
Antibody Isotype
IgG1, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Buffer
PBS
Preservative
0.09% Sodium Azide
Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
tuberous sclerosis 2
Introduction
Tsc2 functions in processes like anoikis, negative regulation of TOR signaling, positive regulation of macroautophagy, regulation of small GTPase mediated signal transduction.
Entrez Gene ID
22084
UniProt ID
Q7TT21
Alternative Names
Tcs2; Nafld
Function
In complex with TSC1, this tumor suppressor inhibits the nutrient-mediated or growth factor-stimulated phosphorylation of S6K1 and EIF4EBP1 by negatively regulating mTORC1 signaling (PubMed:12271141, PubMed:28215400).
Acts as a GTPase-activating protein (GAP) for the small GTPase RHEB, a direct activator of the protein kinase activity of mTORC1 (PubMed:15340059).
May also play a role in microtubule-mediated protein transport (By similarity).
Also stimulates the intrinsic GTPase activity of the Ras-related proteins RAP1A and RAB5 (By similarity).
Biological Process
AnoikisManual Assertion Based On ExperimentIGI:ParkinsonsUK-UCL
EndocytosisManual Assertion Based On ExperimentTAS:ProtInc
Heart developmentISS:UniProtKB
Insulin-like growth factor receptor signaling pathwayISS:UniProtKB
Negative regulation of cell population proliferationISS:UniProtKB
Negative regulation of insulin receptor signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Negative regulation of mitophagy1 PublicationNAS:ParkinsonsUK-UCL
Negative regulation of phosphatidylinositol 3-kinase signalingISS:UniProtKB
Negative regulation of protein kinase activityISS:UniProtKB
Negative regulation of protein kinase B signalingISS:UniProtKB
Negative regulation of TOR signalingManual Assertion Based On ExperimentIDA:ComplexPortal
Negative regulation of Wnt signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Neural tube closureISS:UniProtKB
Positive chemotaxisISS:UniProtKB
Positive regulation of GTPase activityIEA:InterPro
Positive regulation of macroautophagyManual Assertion Based On ExperimentIGI:ParkinsonsUK-UCL
Protein import into nucleusISS:UniProtKB
Protein kinase B signalingISS:UniProtKB
Protein localizationISS:UniProtKB
Regulation of cell cycleManual Assertion Based On ExperimentIBA:GO_Central
Regulation of endocytosisISS:UniProtKB
Regulation of insulin receptor signaling pathwayISS:UniProtKB
Regulation of small GTPase mediated signal transductionIEA:InterPro
Vesicle-mediated transportManual Assertion Based On ExperimentTAS:ProtInc
Cellular Location
Cytoplasm
Membrane
At steady state found in association with membranes.
Involvement in disease
Tuberous sclerosis 2 (TSC2):
An autosomal dominant multi-system disorder that affects especially the brain, kidneys, heart, and skin. It is characterized by hamartomas (benign overgrowths predominantly of a cell or tissue type that occurs normally in the organ) and hamartias (developmental abnormalities of tissue combination). Clinical manifestations include epilepsy, learning difficulties, behavioral problems, and skin lesions. Seizures can be intractable and premature death can occur from a variety of disease-associated causes.
Lymphangioleiomyomatosis (LAM):
Progressive and often fatal lung disease characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. It affects almost exclusively young women and can occur as an isolated disorder or in association with tuberous sclerosis complex.
Focal cortical dysplasia 2 (FCORD2):
A form of focal cortical dysplasia, a malformation of cortical development that results in medically refractory epilepsy in the pediatric population and in adults. FCORD2 is a severe form, with onset usually in childhood, characterized by disrupted cortical lamination and specific cytological abnormalities. It is classified in 2 subtypes: type IIA characterized by dysmorphic neurons and lack of balloon cells; type IIB with dysmorphic neurons and balloon cells.
PTM
Phosphorylation at Ser-1387, Ser-1418 or Ser-1420 does not affect interaction with TSC1. Phosphorylation at Ser-939 and Thr-1462 by PKB/AKT1 is induced by growth factor stimulation. Phosphorylation by AMPK activates it and leads to negative regulation of the mTORC1 complex. Phosphorylated at Ser-1798 by RPS6KA1; phosphorylation inhibits TSC2 ability to suppress mTORC1 signaling. Phosphorylated by DAPK1.
Ubiquitinated by the DCX(FBXW5) E3 ubiquitin-protein ligase complex, leading to its subsequent degradation. Ubiquitinated by MYCBP2 independently of its phosphorylation status leading to subsequent degradation; association with TSC1 protects from ubiquitination.
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-Tsc2 Recombinant Antibody (249CT19.1.3)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare